Press Release
Press Release
Press Contacts: Erik Cummins, Matt Hyams, Olivia Thomas
03.27.23
A Pillsbury team led by New York Mergers & Acquisitions partners Steve Amdur and Bianca Bowen and Tokyo Finance partner Olivia Matsushita advised Japanese chemical manufacturer Sumitomo Chemical Co., Ltd on its acquisition of FBSciences Holdings, Inc. FBSciences is a leader in the growing biorationals market, and developer of biostimulants and biopesticides for softer crop protection and lower environmental hazard. The deal closed March 1, 2023.
The transaction expands Sumitomo Chemical’s existing biorationals business, builds upon the success of its U.S. subsidiary Valent BioSciences LLC, and showcases Sumitomo Chemical’s leadership in developing innovative solutions to enhance the protection of agricultural crops and plants and the sustainable supply of safe and high-quality food.
For more information, click here.
The complex transaction involved a cross-practice team of more than 25 Pillsbury attorneys, including New York-based partners Caroline Harcourt, Ari Berman, Nora Burke and associates Samantha Sharma and Henry Guerra; San Diego-based partner Richard Blaylock, special counsel Michelle Mehok and associate Alexander Graham; Austin-based partner Jessica Lutrin, senior associate Kevin Meil and senior law clerk Chelsea Lawson; Washington, DC-based partners Nancy Fischer, Reza Zarghamee, Brian Coffey, Michael Sibarium, special counsel Rebecca Rizzo, counsels Evan Storm and Aaron Coombs, and associate Laura Killalea; Silicon Valley based counsels Ryan Selness and Mediha Ali; and London based partner Rafi Azim-Khan.